If we fail to scale manufacturing in the United States, then our best bio-innovations will be brewed in China.

Implementation of QbD has been more difficult at the OBP because of the complexity of biotech products. Even so, OBP is already in the process of laying the foundation for a QbD process for ...

For a field with roots stretching back centuries, biotechnology has exploded in recent decades. Today's biotechnologists merge biological processes with advanced technologies to attack some of the ...

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...